Data / Form D filings / Ionogen, Inc.
Ionogen, Inc.: Form D filing
Ionogen, Inc., a biotechnology company in Knoxville, TN, filed a Form D with the SEC in 2019. The latest, on March 8, 2019, reports an offering of $500,000 with nothing sold yet.
Find out what Ionogen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5731 LYON'S VIEW PIKE, Knoxville, TN, 37919
- Phone
- (815) 307-9016
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Tennessee
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1768545
The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2019 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bergein Overholt | Director | |
| William Sansom | Director | |
| Terry Douglass | Director | |
| Douglas Yoakley | Executive Officer, Director | |
| John Shanahan | Executive Officer, Director | |
| Dale Keasling | Director | |
| Rob Zimmer | Executive Officer, Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Mar 4, 2019 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ionogen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.